Expression of the c-Met Proteins in Malignant Skin Cancers
Annals of Dermatology
;
: 33-38, 2011.
Article
Dans Anglais
| WPRIM
| ID: wpr-196213
ABSTRACT
BACKGROUND:
The expression of c-Met is substantially elevated in most malignant human cancers. We therefore searched for c-Met expression and compared the expression level among malignant skin cancers.OBJECTIVE:
The aim of this study was to determine the c-Met expression pattern and the protein expression level in selected malignant cutaneous tumors.METHODS:
G361 cells (malignant melanoma cell line) and A431 cells (squamous cell carcinoma cell line) were cultured and analyzed, using immunoprecipitation and Western blot analysis, for expression of c-Met. Additionally, 16 separate specimens of malignant melanomas (MMs), 16 squamous cell carcinomas (SCCs), 16 basal cell carcinomas (BCCs) and 16 normal tissues were analyzed for the expression of c-Met using immunohistochemical studies.RESULTS:
Based on cultured cell immunoprecipitation and Western blot analysis, both A431 cells and G361 cells expressed c-Met, however, c-Met was expressed substantially more in G361 cells. Immunohistochemical examination of c-Met showed that it was over-expressed in all malignant skin cancers. In addition, c-Met expression was more increased in MM compared to other cancers.CONCLUSION:
In our study, c-Met is involved in malignant skin cancer development and the level of its expression is thought to be related to the degree of malignancy in melanoma cancers.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Peau
/
Tumeurs cutanées
/
Carcinome basocellulaire
/
Carcinome épidermoïde
/
Cellules cultivées
/
Technique de Western
/
Protéines proto-oncogènes c-met
/
Immunoprécipitation
/
Mélanome
Limites du sujet:
Humains
langue:
Anglais
Texte intégral:
Annals of Dermatology
Année:
2011
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS